Atlas Trials

BromhexIne And Spironolactone For CoronаVirUs Infection Requiring HospiTalization

Clinical trial NCT04424134 · UNKNOWN

Trial details

NCT number
NCT04424134
Sponsor
Lomonosov Moscow State University Medical Research and Educational Center
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
COVID 19
Start date
2020-05-16
Primary completion
2020-07-18
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.